Vantictumab

Contact Us

Products

Quote Request

Catalog No.: PC0114

Size: 1 mg, 5 mg,10 mg, 50 mg, 100 mg

Description

Vantictumab (OMP-18R5) is a fully human IgG2 monoclonal antibody that inhibits Wnt pathway signaling by binding to FZD1/2/5/7/8 receptors. It can be studied to treat cancers such as metastatic HER2-negative breast cancer and metastatic pancreatic cancer.

CAS No.	1345009-45-1
Appearance	Liquid
Color	Colorless to light yellow
Shipping	Shipping with dry ice.
Storage	Please store the product under the recommended conditions in the Certificate of Analysis.

All of our services are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

As science and technology continue to evolve, Alfa Cytology, as a provider of preclinical research services, is committed to maintaining the pace of progress, providing pancreatic cancer-related solutions that leverage existing resources to help our customers accelerate research and development.

By Molecule Type

By Research Phase

Company